SCHEMBL13523744

SCHEMBL13523744

CC(Cc1cnccn1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.44
MAOB P27338 3/20 0.44
NISCH Q9Y2I1 3/20 0.44
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
TAAR1 Q96RJ0 2/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
GAA P10253 1/20 0.40
THRB P10828 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10087892 0.80 GRIN2D (0.62) MAOAMAOBNISCHESR1ESR2
SCHEMBL8862948 0.80 CYP3A4 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27834814 0.79 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13200763 0.79 KDM4E (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8308573 0.79 GRIN2D (0.67) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8862553 0.79 CYP1A2 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL8862777 0.78 CYP3A4 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6813229 0.76 GAA (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7824760 0.76 GAA (0.50) CYP2C9CYP2C19GAATHRBKDM4E
SCHEMBL7824762 0.76 GAA (0.50) CYP2C9CYP2C19GAATHRBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1935887-B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands AVENTIS PHARMA INC (US) 2010-01-13 EP disclosed